Ward A
Biomedicines. 2025; 13(2).
PMID: 40002910
PMC: 11853056.
DOI: 10.3390/biomedicines13020497.
Yagi T, Kinose Y, Koizumi M, Iwamiya T, Ito F, Kubota S
Cureus. 2024; 16(11):e74163.
PMID: 39712704
PMC: 11663040.
DOI: 10.7759/cureus.74163.
Borgeaud M, Perano S, Addeo A, Tsantoulis P
Future Oncol. 2024; 20(29):2203-2212.
PMID: 39440714
PMC: 11509001.
DOI: 10.1080/14796694.2024.2349510.
Nates J, Pene F, Darmon M, Mokart D, Castro P, David S
Crit Care. 2024; 28(1):285.
PMID: 39215292
PMC: 11363658.
DOI: 10.1186/s13054-024-05073-0.
Sato R, Matsushita Y, Sano A, Watanabe K, Watanabe H, Tamura K
In Vivo. 2024; 38(4):1859-1864.
PMID: 38936944
PMC: 11215579.
DOI: 10.21873/invivo.13640.
Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy.
Cheng Y, Zhao Y, Xu M, Du H, Sun J, Yao Q
Front Immunol. 2024; 15:1386071.
PMID: 38881899
PMC: 11176469.
DOI: 10.3389/fimmu.2024.1386071.
Severe Pseudomonas aeruginosa Pneumonia in a Breast Cancer Patient Despite Pegfilgrastim Administration.
Fukuma Y, Nomura T, Mikami T, Tanaka K, Taira N
Cureus. 2024; 16(3):e57156.
PMID: 38686264
PMC: 11057642.
DOI: 10.7759/cureus.57156.
Predictive Role of Pre-Operative Anemia in Early Recurrence of Endometrial Cancer: A Single-Center Study in Romania.
Ionica M, Biris M, Gorun F, Nicolae N, Popa Z, Muresan M
J Clin Med. 2024; 13(3).
PMID: 38337488
PMC: 10856108.
DOI: 10.3390/jcm13030794.
A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report.
Patodiya B, Ramani V, Rao P, Sharma M, Patodiya S, Reddy D
SAGE Open Med Case Rep. 2023; 11:2050313X231208968.
PMID: 37954540
PMC: 10637155.
DOI: 10.1177/2050313X231208968.
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer.
Aapro M, Chaplin S, Cornes P, Howe S, Link H, Koptelova N
Support Care Cancer. 2023; 31(10):581.
PMID: 37728795
PMC: 10511548.
DOI: 10.1007/s00520-023-08043-4.
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A....
Park K, Jeon Y, Kim J, Choi Y, Kim J, Oh S
Medicine (Baltimore). 2023; 102(20):e33638.
PMID: 37335745
PMC: 10194448.
DOI: 10.1097/MD.0000000000033638.
Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor.
Zhao T, Wang Y, Zhou D, Zhang W
Open Life Sci. 2023; 18(1):20220590.
PMID: 37070077
PMC: 10105549.
DOI: 10.1515/biol-2022-0590.
Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis.
Reinhardt B, Lee P, Sasine J
Cells. 2023; 12(4).
PMID: 36831198
PMC: 9954220.
DOI: 10.3390/cells12040531.
Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type.
Alrawashdh N, McBride A, Oh M, Alkhatib N, Lee C, Martin J
J Adv Pract Oncol. 2023; 13(8):796-811.
PMID: 36727017
PMC: 9881740.
DOI: 10.6004/jadpro.2022.13.8.6.
Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis.
Aslam S, Li E, Bell E, Lal L, Anderson A, Peterson-Brandt J
J Manag Care Spec Pharm. 2023; 29(2):128-138.
PMID: 36705281
PMC: 10387928.
DOI: 10.18553/jmcp.2023.29.2.128.
Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy.
Moro K, Nagahashi M, Uchida H, Oji M, Tsuchida J, Yamaura K
World J Oncol. 2023; 13(6):379-386.
PMID: 36660211
PMC: 9822686.
DOI: 10.14740/wjon1530.
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement.
Adamo V, Antonuzzo L, Danova M, De Laurentiis M, Marchetti P, Pinto C
Support Care Cancer. 2022; 30(12):9877-9888.
PMID: 36334157
PMC: 9715510.
DOI: 10.1007/s00520-022-07430-7.
Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients.
van Laar S, Gombert-Handoko K, Wassenaar S, Kroep J, Guchelaar H, Zwaveling J
Support Care Cancer. 2022; 30(11):9181-9189.
PMID: 36044088
PMC: 9633501.
DOI: 10.1007/s00520-022-07343-5.
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
Morizane C, Machida N, Honma Y, Okusaka T, Boku N, Kato K
JAMA Oncol. 2022; 8(10):1447-1455.
PMID: 35980649
PMC: 9389440.
DOI: 10.1001/jamaoncol.2022.3395.
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma.
Shimano R, Yamamoto H, Nasu I, Kashiwamura Y, Yamamoto G, Uchida N
Int J Hematol. 2022; 116(6):856-862.
PMID: 35976562
DOI: 10.1007/s12185-022-03438-1.
